High-resolution cryo-EM proteasome structures in drug development.

Area of Science:

• Structural Biology
• Biochemistry
• Biophysics

Background:

• Recent advances in biological structural electron microscopy (EM) allow protein structure determination at resolutions comparable to crystallographic or NMR methods.
• The human 20S proteasome is a validated cancer therapy target and is being investigated for other medical conditions.
• Understanding protein-ligand interactions is crucial for drug development and disease treatment.

Purpose of the Study:

• To demonstrate the application of cryo-EM for studying protein-ligand interactions using the human 20S proteasome.
• To determine the cryo-EM structure of the Plasmodium falciparum 20S proteasome with a novel inhibitor.
• To provide a framework for developing new antimalarials based on parasite proteasome inhibition.

Main Methods:

• Cryo-electron microscopy (cryo-EM) and single-particle analysis were employed for structure determination.
• The icr3d software was utilized for three-dimensional reconstruction.
• Specific strategies were developed to overcome orientation bias in human 20S proteasome samples.

Main Results:

• Cryo-EM successfully determined the structure of ligand-bound human 20S proteasome, validating its utility for protein-ligand interaction studies.
• The cryo-EM structure of Plasmodium falciparum 20S proteasome with a specific inhibitor revealed the molecular basis of ligand specificity.
• This structural information can guide the development of targeted antimalarial drugs.

Conclusions:

• Cryo-EM is a powerful and versatile technique for structural studies of protein-ligand interactions, even for challenging complexes.
• Determining the structure of the Plasmodium falciparum 20S proteasome provides critical insights for antimalarial drug discovery.
• The methods described enable structure determination closer to physiological conditions, preserving ligand specificity.